Whatmore A - Search Results

1

A pilot interventional study to evaluate the impact of cholecalciferol treatment on HbA1c in type 1 diabetes (T1D).

Perchard R, Magee L, Whatmore A, Ivison F, Murray P, Stevens A, Mughal MZ, Ehtisham S, Campbell J, Ainsworth S, Marshall M, Bone M, Doughty I, Clayton PE. Perchard R, et al. Among authors: whatmore a. Endocr Connect. 2017 May;6(4):225-231. doi: 10.1530/EC-17-0045. Epub 2017 Apr 5. Endocr Connect. 2017. PMID: 28381562 Free PMC article.

2

Infradian rhythms in urinary growth hormone excretion.

Thalange NK, Gill MS, Gill L, Whatmore AJ, Addison GM, Price DA, Clayton PE. Thalange NK, et al. Among authors: whatmore aj. J Clin Endocrinol Metab. 1996 Jan;81(1):100-6. doi: 10.1210/jcem.81.1.8550735. J Clin Endocrinol Metab. 1996. PMID: 8550735

3

Insulin-like growth factor binding protein-3 generation: an index of growth hormone insensitivity.

Thalange NK, Price DA, Gill MS, Whatmore AJ, Addison GM, Clayton PE. Thalange NK, et al. Among authors: whatmore aj. Pediatr Res. 1996 May;39(5):849-55. doi: 10.1203/00006450-199605000-00018. Pediatr Res. 1996. PMID: 8726240

4

Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome.

Freeth JS, Ayling RM, Whatmore AJ, Towner P, Price DA, Norman MR, Clayton PE. Freeth JS, et al. Among authors: whatmore aj. Endocrinology. 1997 Jan;138(1):55-61. doi: 10.1210/endo.138.1.4853. Endocrinology. 1997. PMID: 8977385

5

Biochemical tests in the diagnosis of childhood growth hormone deficiency.

Tillmann V, Buckler JM, Kibirige MS, Price DA, Shalet SM, Wales JK, Addison MG, Gill MS, Whatmore AJ, Clayton PE. Tillmann V, et al. Among authors: whatmore aj. J Clin Endocrinol Metab. 1997 Feb;82(2):531-5. doi: 10.1210/jcem.82.2.3750. J Clin Endocrinol Metab. 1997. PMID: 9024249

6

Urinary IGF and IGF binding protein-3 in children with disordered growth. The North West Paediatric Endocrine Group.

Gill MS, Whatmore AJ, Tillman V, White A, Addison GM, Price DA, Clayton PE. Gill MS, et al. Among authors: whatmore aj. Clin Endocrinol (Oxf). 1997 Apr;46(4):483-92. doi: 10.1046/j.1365-2265.1997.1670981.x. Clin Endocrinol (Oxf). 1997. PMID: 9196612

7

Serum leptin through childhood and adolescence.

Clayton PE, Gill MS, Hall CM, Tillmann V, Whatmore AJ, Price DA. Clayton PE, et al. Among authors: whatmore aj. Clin Endocrinol (Oxf). 1997 Jun;46(6):727-33. doi: 10.1046/j.1365-2265.1997.2081026.x. Clin Endocrinol (Oxf). 1997. PMID: 9274704

8

Activation of the signal transducers and activators of transcription signaling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron Syndrome children.

Freeth JS, Silva CM, Whatmore AJ, Clayton PE. Freeth JS, et al. Among authors: whatmore aj. Endocrinology. 1998 Jan;139(1):20-8. doi: 10.1210/endo.139.1.5690. Endocrinology. 1998. PMID: 9421393

9

Serum insulin-like growth factor-I, IGF binding protein-3 and IGFBP-3 protease activity after cranial irradiation.

Tillmann V, Shalet SM, Price DA, Wales JK, Pennells L, Soden J, Gill MS, Whatmore AJ, Clayton PE. Tillmann V, et al. Among authors: whatmore aj. Horm Res. 1998;50(2):71-7. doi: 10.1159/000023237. Horm Res. 1998. PMID: 9701699

10

Signal transduction defects in growth hormone insensitivity.

Clayton PE, Freeth JS, Whatmore AJ, Ayling RM, Norman MR, Silva CM. Clayton PE, et al. Among authors: whatmore aj. Acta Paediatr Suppl. 1999 Feb;88(428):174-8; discussion 179. doi: 10.1111/j.1651-2227.1999.tb14382.x. Acta Paediatr Suppl. 1999. PMID: 10102076 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page